|
CCMP Capital is a private equity investment firm that focuses on leveraged buyout and growth capital transactions. Formerly known as JP Morgan Partners, the investment professionals of JP Morgan Partners separated from JPMorgan Chase on July 31, 2006. CCMP has invested approximately $12 billion in leveraged buyout and growth capital transactions since inception. In 2007, CCMP was ranked #17 among World's largest private equity funds.〔Private Equity International's list of the (50 largest private equity firms )〕 CCMP has over 50 employees with offices in New York, London, Hong Kong and Tokyo. In 2008, CCMP hired Greg Brenneman as chairman.〔("Eddie Bauer Files for Bankruptcy" ) by Stephanie Rosenbloom and Michael J. de la Merced, ''The New York Times'', June 17, 2009 (6/18/09, p. B3, NY ed.). Retrieved 6/18/09.〕 ==History== CCMP has been known by several names over the past two decades, originally founded as Chemical Venture Partners in 1984, to serve as the private equity and venture capital arm of Chemical Bank. Following Chemical's acquisition of Chase Manhattan Bank in 1996, Chemical adopted the Chase name and Chemical Venture Partners changed its name to Chase Capital Partners. Similarly, following the 2000 acquisition of J.P. Morgan & Co. and the formation of JPMorgan Chase, the group changed its name yet again to JP Morgan Partners. Over this time, the platform grew through its integration of the private equity organizations of Manufacturers Hanover, Chase Manhattan, Hambrecht & Quist, Robert Fleming & Co., The Beacon Group and J.P. Morgan & Co. In 2004, JPMorgan Chase completed its acquisition of Bank One which had its own in house private equity investment group, One Equity Partners.〔One Equity Partners manages approximately $8 billion in private equity commitments for JPMorgan Chase〕 One Equity, led by Dick Cashin was ultimately designated as the lead private equity platform for JPMorgan Chase at which point JP Morgan Partners formalized plans to spin out of JPMorgan Chase.〔(Bear Stearns private equity units face uncertain future ) (Private Equity Online, 2008)〕 JP Morgan Partners announced the spinout in March 2005 and completed the separation from JPMorgan Chase effective July 31, 2006.〔(JPMorgan Chase Announces Changes to Private Equity Business. )〕 The new firm adopted the CCMP acronym in reference to its predecessor entities (i.e., Chemical and Chase and JP Morgan Partners). In April 2006, JPMorgan Chase completed the sale of a $925 million interest in JP Morgan Partners Global Fund to a consortium of secondary investors.〔(Goldman and Canada in $925m JP Morgan deal ) (Dow Jones Financial News, 2006).〕 The spinout of CCMP came at the same time as the spinouts of private equity groups from other leading investment banks including: Morgan Stanley (Metalmark Capital), Citigroup (Court Square Capital Partners), Deutsche Bank (MidOcean Partners) and Credit Suisse First Boston (Avista Capital Partners, Diamond Castle Holdings). In 2007, CCMP completed fundraising for its most recent fund, closing on $3.4 billion in commitments from institutional investors for CCMP Capital Investors II. CCMP Capital Investors II, represented the first fund raised by the CCMP team subsequent to its split from JPMorgan Chase and came in slightly below the original $3.5 billion target that CCMP set for the fundraising. In February 2014, CCMP sold the pharmaceutical contract research organisation Medpace to Cinven for around $900 million. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「CCMP Capital」の詳細全文を読む スポンサード リンク
|